2026 Scrip Asia 100
Latest Updates And Considerations In Asia Pacific
Generative AI, bold innovation in Japan, and Korea’s push for quality data show how digital tools are redefining pharma R&D. The future of drug discovery is being shaped by convergence, credibility, and speed.
Heads of Novartis Biomedical, World Economic Forum and Indian majors like Sun Pharma’s SPARC, among others, discuss generative AI in drug discovery along with pointers for India to leapfrog the R&D process
Bringing supercomputing power to bear on large-scale calculations for pharma R&D, Tokyo-based Xeureka explains the practical use of AI to empower innovation beyond the hype.
AI-powered drug development was a major topic at the recent Bio Korea meeting, where experts discussed how the technology is changing R&D activities and the challenges being faced by Korean firms as they look to catch up with their global competitors.
